Table 4.

Characteristics of detected HSV-infections and treatment. Results above 500 Geq/ml were considered positive.

Treatment with acyclovir (yes, %)	53 (86.9)
Duration of treatment (in days) (median [IQR])	12 [8 to 16]
Treatment with additional anti-infective therapy n = no (%)	10 (17.9)
Ongoing SarsCoV infection = no (%)	29 (49.2)
Number of dosages per day (%)
1	8 (13.1)
2	2 (3.3)
3	42 (68.9)
Single dosage in mg (%)
375	3 (5.9)
750	47 (92.2)
1250	1 (2.2)
Total dosage per day (median [IQR])	2250 [2250 to 2250]
Dosage per bodyweight in kg (median [IQR])	9.4 [7.7 to 10.0]
HSV peak in Geq/ml (median [IQR])	2150000 [183775 to 28250000]
Number of BAL samples (median [IQR])	5 [3 to 8]
LOS ICU until first positive sample	9.00 [7 to 13]

LOS, length of stay; ICU, intensive care unit; IQ, interquartile range; HSV, Herpes simplex virus; BAL, bronchoalveolar lavage.